High Glucose with Insulin Induces Cell Cycle Progression and Activation of Oncogenic Signaling of Bladder Epithelial Cells Cotreated with Metformin and Pioglitazone
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High Glucose with Insulin Induces Cell Cycle Progression and Activation of Oncogenic Signaling of Bladder Epithelial Cells Cotreated with Metformin and Pioglitazone
Authors
Keywords
-
Journal
Journal of Diabetes Research
Volume 2019, Issue -, Pages 1-10
Publisher
Hindawi Limited
Online
2019-01-10
DOI
10.1155/2019/2376512
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study
- (2018) Shao-ling Yang et al. International Journal of Medical Sciences
- Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer
- (2018) Di Wu et al. NATURE
- Oxidative Stress in Pancreatic Beta Cell Regeneration
- (2017) Jingjing Wang et al. Oxidative Medicine and Cellular Longevity
- Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes
- (2016) E. Erdmann et al. DIABETES OBESITY & METABOLISM
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries
- (2016) Pasi Korhonen et al. BMJ-British Medical Journal
- Pioglitazone use and risk of bladder cancer: population based cohort study
- (2016) Marco Tuccori et al. BMJ-British Medical Journal
- Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries
- (2016) Pasi Korhonen et al. BMJ-British Medical Journal
- Pioglitazone use and risk of bladder cancer: population based cohort study
- (2016) Marco Tuccori et al. BMJ-British Medical Journal
- Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study
- (2016) Todd A. Mackenzie et al. Diabetes Therapy
- Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study
- (2016) Todd A. Mackenzie et al. Diabetes Therapy
- Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes
- (2015) James D. Lewis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo
- (2015) Ramandeep Rattan et al. NEOPLASIA
- Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP
- (2014) Tao Zhang et al. ANTI-CANCER DRUGS
- Cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan
- (2014) Cheng-Chieh Lin et al. BMC CANCER
- Sequential treatment of HPV E6 and E7-expressing TC-1 cells with bortezomib and celecoxib promotes apoptosis through p-p38 MAPK-mediated downregulation of cyclin D1 and CDK2
- (2014) JEE-EUN KIM et al. ONCOLOGY REPORTS
- The influence of high glucose and high insulin on mechanisms controlling cell cycle progression and arrest in mouse C2C12 myoblasts: the comparison with IGF-I effect
- (2014) K. Grabiec et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies
- (2013) Zhaowei Zhu et al. BMC CANCER
- Comparing Pioglitazone to Insulin with Respect to Cancer, Cardiovascular and Bone Fracture Endpoints, Using Propensity Score Weights
- (2013) Carlos Vallarino et al. CLINICAL DRUG INVESTIGATION
- The Antidiabetic Drug Metformin Inhibits the Proliferation of Bladder Cancer Cells in Vitro and in Vivo
- (2013) Tao Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pioglitazone use and the risk of bladder cancer
- (2013) Hsin-Wei Kuo et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies
- (2013) Xin Xu et al. PLoS One
- Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
- (2013) Monica Franciosi et al. PLoS One
- Metformin and breast cancer risk: a meta-analysis and critical literature review
- (2012) Nananda F. Col et al. BREAST CANCER RESEARCH AND TREATMENT
- Pioglitazone and bladder cancer: a propensity score matched cohort study
- (2012) Li Wei et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Transcriptional Amplification in Tumor Cells with Elevated c-Myc
- (2012) Charles Y. Lin et al. CELL
- Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes
- (2012) Kanta Fujimoto et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
- (2012) A. Neumann et al. DIABETOLOGIA
- Thiazolidinedione safety
- (2012) Jacqueline Kung et al. Expert Opinion On Drug Safety
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
- (2012) Hiroshi Noto et al. PLoS One
- The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
- (2012) L. Azoulay et al. BMJ-British Medical Journal
- The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells
- (2011) Alejandro Vazquez-Martin et al. CELL CYCLE
- Pioglitazone and Bladder Cancer: A population-based study of Taiwanese
- (2011) C.-H. Tseng DIABETES CARE
- Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study
- (2011) J. D. Lewis et al. DIABETES CARE
- Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting
- (2011) C. Piccinni et al. DIABETES CARE
- Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladder
- (2011) HENNING REIS et al. Oncology Letters
- Metformin and Other Biguanides in Oncology: Advancing the Research Agenda
- (2010) M. Pollak Cancer Prevention Research
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Metformin: Taking away the candy for cancer?
- (2010) Mathilde Jalving et al. EUROPEAN JOURNAL OF CANCER
- Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway
- (2010) Qingshan Yang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Fat and Beyond: The Diverse Biology of PPARγ
- (2008) Peter Tontonoz et al. Annual Review of Biochemistry
- CDK Inhibitors: Cell Cycle Regulators and Beyond
- (2008) Arnaud Besson et al. DEVELOPMENTAL CELL
- Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men
- (2008) Susanna C. Larsson et al. EUROPEAN JOURNAL OF CANCER
- PPARγ2 expression in growth plate chondrocytes is regulated by p38 and GSK-3
- (2008) Lee-Anne Stanton et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
- (2008) M. J. Gunter et al. JNCI-Journal of the National Cancer Institute
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started